Human Health Holdings Limited (01419) released its Monthly Return for Equity Issuer for the period ended 31 January 2026. The announcement shows no change in the company’s authorised share capital, which remains at HKD100,000,000 comprising 10,000,000,000 ordinary shares at a par value of HKD0.01 each.

According to the report, there was no change in the total issued shares, and the balance at the close of January 2026 remained at 379,552,233 ordinary shares. There were no treasury shares and no new shares issued during the period. The public float requirement of 25% minimum has been confirmed met.

Regarding share options, 150,000 options remained outstanding under the terminated scheme. No additional options were issued or exercised during the month. The newly adopted scheme, established on 10 December 2025, had no changes or options granted as of the end of January 2026.

All other details, including warrants, convertibles, and other arrangements, were marked as not applicable, indicating no relevant movements during this reporting period.